Vollset, S. E. et al. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403, 2204–2256 (2024).
Google Scholar
O’Hearn, M. et al. Incident type 2 diabetes attributable to suboptimal diet in 184 countries. Nat. Med. 29, 982–995 (2023).
Google Scholar
Sandforth, L. et al. Prediabetes remission to reduce the global burden of type 2 diabetes. Trends Endocrinol. Metab. S1043-2760, 00004-9 (2025).
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J. & Kivimäki, M. Prediabetes: a high-risk state for diabetes development. Lancet 379, 2279–2290 (2012).
Google Scholar
Ligthart, S. et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 4, 44–51 (2016).
Google Scholar
Chow, H.-M. et al. Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence. Nat. Neurosci. 22, 1806–1819 (2019).
Google Scholar
Huang, Y. et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 57, 2261–2269 (2014).
Google Scholar
ElSayed, N. A. et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 46, S19–S40 (2023).
Google Scholar
American Diabetes Association Professional Practice Committee. Prevention or delay of diabetes and associated comorbidities: standards of care in diabetes-2025. Diabetes Care 48, S50–S58 (2025).
Perreault, L. et al. Regression from prediabetes to normal glucose regulation and prevalence of microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes Care 42, 1809–1815 (2019).
Google Scholar
Perreault, L. et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379, 2243–2251 (2012).
Google Scholar
Fritsche, A. et al. Different effects of lifestyle intervention in high- and low-risk prediabetes: results of the randomized controlled Prediabetes Lifestyle Intervention Study (PLIS). Diabetes 70, 2785–2795 (2021).
Google Scholar
Sandforth, A. et al. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS). Lancet Diabetes Endocrinol. 11, 798–810 (2023).
Google Scholar
Birkenfeld, A. L. & Mohan, V. Prediabetes remission for type 2 diabetes mellitus prevention. Nat. Rev. Endocrinol. 20, 441–442 (2024).
Google Scholar
Lean, M. E. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541–551 (2018).
Google Scholar
Lean, M. E. et al. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol. 12, 233–246 (2024).
Google Scholar
Petersen, A. M. W. & Pedersen, B. K. The anti-inflammatory effect of exercise. J. Appl. Physiol. (1985) 98, 1154–1162 (2005).
Google Scholar
Gleeson, M. et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11, 607–615 (2011).
Google Scholar
Hughes, V. A. et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am. J. Physiol. 264, E855–E862 (1993).
Google Scholar
Boulé, N. G., Haddad, E., Kenny, G. P., Wells, G. A. & Sigal, R. J. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286, 1218–1227 (2001).
Google Scholar
Zhyzhneuskaya, S. V. et al. Time course of normalization of functional β-cell capacity in the diabetes remission clinical trial after weight loss in type 2 diabetes. Diabetes Care 43, 813–820 (2020).
Google Scholar
Wagner, R. et al. Lower hepatic fat is associated with improved insulin secretion in a high-risk prediabetes subphenotype during lifestyle intervention. Diabetes 72, 362–366 (2022).
Google Scholar
Preis, S. R. et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study. Obesity (Silver Spring) 18, 2191–2198 (2010).
Google Scholar
Karlsson, T. et al. Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease. Nat. Med. 25, 1390–1395 (2019).
Google Scholar
Al-Mrabeh, A. et al. Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metab. 31, 233–249 (2020).
Google Scholar
van Vliet, S. et al. Obesity is associated with increased basal and postprandial β-cell insulin secretion even in the absence of insulin resistance. Diabetes 69, 2112–2119 (2020).
Google Scholar
Cauter, E. V., Mestrez, F., Sturis, J. & Polonsky, K. S. Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41, 368–377 (1992).
Google Scholar
Smith, G. I. et al. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. J. Clin. Invest. 130, 3305–3314 (2020).
Google Scholar
Bergman, M. et al. International diabetes federation position statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. Diabetes Res. Clin. Pract. 209, 111589 (2024).
Google Scholar
Gaesser, G. A. & Angadi, S. S. Obesity treatment: weight loss versus increasing fitness and physical activity for reducing health risks. iScience 24, 102995 (2021).
Google Scholar
Lee, S. et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes. J. Appl. Physiol. (1985) 99, 1220–1225 (2005).
Google Scholar
Ross, R. et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes. Res. 12, 789–798 (2004).
Google Scholar
Rosqvist, F. et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 63, 2356–2368 (2014).
Google Scholar
Petersen, K. F. et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 4, 603–608 (2005).
Google Scholar
Coral, D. E. et al. Subclassification of obesity for precision prediction of cardiometabolic diseases. Nat. Med. 31, 534–543 (2025).
Google Scholar
Rubino, F. et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 13, 221–262 (2025).
Google Scholar
Busetto, L. et al. A new framework for the diagnosis, staging and management of obesity in adults. Nat. Med. 30, 2395–2399 (2024).
Google Scholar
Amati, F. et al. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity (Silver Spring) 20, 1115–1117 (2012).
Google Scholar
Ahn, C. et al. Exercise training remodels subcutaneous adipose tissue in adults with obesity even without weight loss. J. Physiol. 600, 2127–2146 (2022).
Google Scholar
Long-term exercise training has positive effects on adipose tissue in overweight or obesity. Nat. Metab. 6, 1657–1658 (2024).
Houmard, J. A. et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J. Appl. Physiol. (1985) 96, 101–106 (2004).
Google Scholar
Smith, K. et al. Multi-ancestry polygenic mechanisms of type 2 diabetes. Nat. Med. 30, 1065–1074 (2024).
Google Scholar
Hodgson, S. et al. Genetic basis of early onset and progression of type 2 diabetes in South Asians. Nat. Med. 31, 323–331 (2025).
Google Scholar
Lotta, L. A. et al. Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors. JAMA 320, 2553–2563 (2018).
Google Scholar
Mayerson, A. B. et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51, 797–802 (2002).
Google Scholar
Carey, D. G. et al. Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected]. Obes. Res. 10, 1008–1015 (2002).
Google Scholar
Gastaldelli, A. et al. Thiazolidinediones improve β-cell function in type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab. 292, E871–E883 (2007).
Google Scholar
Klöting, N. et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299, E506–E515 (2010).
Google Scholar
Petersen, M. C. et al. Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. Cell Metab. 36, 745–761 (2024).
Google Scholar
White, M. G. et al. Expression of mesenchymal and α-cell phenotypic markers in Islet β-cells in recently diagnosed diabetes. Diabetes Care 36, 3818–3820 (2013).
Google Scholar
Nauck, M. A., Baller, B. & Meier, J. J. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 53, S190–S196 (2004).
Google Scholar
Vilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S. & Holst, J. J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50, 609–613 (2001).
Google Scholar
Toft-Nielsen, M. B. et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 86, 3717–3723 (2001).
Google Scholar
Ritzel, R. et al. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. Diabetes 50, 776–784 (2001).
Google Scholar
Jones, I. R., Owens, D. R., Luzio, S., Williams, S. & Hayes, T. M. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32, 668–677 (1989).
Google Scholar
Vilsbøll, T., Krarup, T., Madsbad, S. & Holst, J. J. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia 45, 1111–1119 (2002).
Google Scholar
Bagger, J. I. et al. Glucagonostatic potency of GLP-1 in patients with type 2 diabetes, patients with type 1 diabetes, and healthy control subjects. Diabetes 70, 1347–1356 (2021).
Google Scholar
Nauck, M. A. et al. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J. Clin. Endocrinol. Metab. 87, 1239–1246 (2002).
Google Scholar
Schuppelius, B. et al. Alterations in glucagon levels and the glucagon-to-insulin ratio in response to high dietary fat or protein intake in healthy lean adult twins: a post hoc analysis. Nutrients 16, 3905 (2024).
Google Scholar
Jumpertz von Schwartzenberg, R., Vazquez Arreola, E., Sandforth, A., Hanson, R. L. & Birkenfeld, A. L. Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention. Diabetologia 67, 1714–1718 (2024).
Google Scholar
Kahn, S. E. et al. Effect of semaglutide on regression and progression of glycemia in people with overweight or obesity but without diabetes in the SELECT trial. Diabetes Care 47, 1350–1359 (2024).
Google Scholar
Pajvani, U. B. et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152–12162 (2004).
Google Scholar
Riera-Guardia, N. & Rothenbacher, D. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes. Metab. 10, 367–375 (2008).
Google Scholar
Doehner, W. et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int. J. Cardiol. 162, 20–26 (2012).
Google Scholar
Arreola, E. V. et al. Prediabetes remission and cardiovascular morbidity and mortality: a post-hoc analysis from DPPOS and DaQingDPOS. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5317664 (2025).
Vazquez Arreola et al. Prediabetes Remission and Cardiovascular Morbidity and Mortality: A post-hoc analysis from the Diabetes Prevention Program Outcome Study and the DaQing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinology; provisionally accepted.
Grattan, B. J. & Connolly-Schoonen, J. Addressing weight loss recidivism: a clinical focus on metabolic rate and the psychological aspects of obesity. ISRN Obes. 2012, 567530 (2012).
Google Scholar
Fildes, A. et al. Probability of an obese person attaining normal body weight: cohort study using electronic health records. Am. J. Public Health 105, e54–e59 (2015).
Google Scholar
Sandforth, L. et al. Subphenotype-dependent benefits of bariatric surgery for individuals at risk for type 2 diabetes. Diabetes Care 48, 996–1006 (2025).
Google Scholar
Taylor, R. et al. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery. Cell Metab. 28, 547–556 (2018).
Google Scholar
Chadha, C. et al. Reproducibility of a prediabetes classification in a contemporary population. Metab. Open 6, 100031 (2020).
Google Scholar
Lazo-Porras, M. et al. Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: the CRONICAS cohort study. Diabetes Res. Clin. Pract. 163, 107829 (2020).
Google Scholar
Birkenfeld, A. L., Franks, P. W. & Mohan, V. Precision medicine in people at risk for diabetes and atherosclerotic cardiovascular disease: a fresh perspective on prevention. Circulation 150, 1910–1912 (2024).
Google Scholar
Baecke, J. A., Burema, J. & Frijters, J. E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 36, 936–942 (1982).
Google Scholar
Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).
Google Scholar
Fowler, S. Diabetes Prevention Program (DPP) (version 9). NIDDK Central Repository https://doi.org/10.58020/3HW5-CF91 (2024).
Mari, A., Pacini, G., Murphy, E., Ludvik, B. & Nolan, J. J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24, 539–548 (2001).
Google Scholar
Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462–1470 (1999).
Google Scholar
Gastaldelli, A. et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50, 1087–1093 (2009).
Google Scholar
O’Donovan, S. D. et al. Improved quantification of muscle insulin sensitivity using oral glucose tolerance test data: the MISI calculator. Sci. Rep. 9, 9388 (2019).
Google Scholar
Abdul-Ghani, M. A., Matsuda, M., Balas, B. & DeFronzo, R. A. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30, 89–94 (2007).
Google Scholar
Tura, A., Kautzky-Willer, A. & Pacini, G. Insulinogenic indices from insulin and C-peptide: comparison of β-cell function from OGTT and IVGTT. Diabetes Res. Clin. Pract. 72, 298–301 (2006).
Google Scholar
Ahrén, B., Pacini, G., Foley, J. E. & Schweizer, A. Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care 28, 1936–1940 (2005).
Google Scholar
Piccinini, F. & Bergman, R. N. The measurement of insulin clearance. Diabetes Care 43, 2296–2302 (2020).
Google Scholar
Allison, D. B., Paultre, F., Maggio, C., Mezzitis, N. & Pi-Sunyer, F. X. The use of areas under curves in diabetes research. Diabetes Care 18, 245–250 (1995).
Google Scholar
de Jesús Garduno-Garcia, J. et al. Older subjects with β-cell dysfunction have an accentuated incretin release. J. Clin. Endocrinol. Metab. 103, 2613–2619 (2018).
Google Scholar
Yamazaki, H. et al. Fat distribution patterns and future type 2 diabetes. Diabetes 71, 1937–1945 (2022).
Google Scholar
Machann, J. et al. Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 257, 353–363 (2010).
Google Scholar
Würslin, C. et al. Topography mapping of whole body adipose tissue using a fully automated and standardized procedure. J. Magn. Reson. Imaging 31, 430–439 (2010).
Google Scholar
Liu, C.-Y., McKenzie, C. A., Yu, H., Brittain, J. H. & Reeder, S. B. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn. Reson. Med. 58, 354–364 (2007).
Google Scholar
Kim, H. et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn. Reson. Med. 59, 521–527 (2008).
Google Scholar
Machann, J. et al. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn. Reson. Med. 55, 913–917 (2006).
Google Scholar
Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917 (1959).
Google Scholar
Coman, C. et al. Simultaneous metabolite, protein, lipid extraction (SIMPLEX): a combinatorial multimolecular omics approach for systems biology. Mol. Cell. Proteomics 15, 1453–1466 (2016).
Google Scholar
Herzog, R. et al. LipidXplorer: a software for consensual cross-platform lipidomics. PLoS ONE 7, e29851 (2012).
Google Scholar
Liu, M. Y. et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin. Chem. 51, 1102–1109 (2005).
Google Scholar
Rasmussen, C. et al. Preanalytical impact on the accuracy of measurements of glucagon, GLP-1 and GIP in clinical trials. Scand. J. Clin. Lab. Invest. 83, 591–598 (2023).
Google Scholar
Sollis, E. et al. The NHGRI–EBI GWAS catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, D977–D985 (2023).
Google Scholar
NIDDK-CR Resources for Research (R4R). NIDDK Central Repository https://repository.niddk.nih.gov/home (2025).
